Welcome back to TechCrunch Mobility, your hub for the future of transportation and now, more than ever, how AI is playing a part. To get this in your inbox, sign up here for free — just click TechCrunch Mobility! If you’re into EVs or sports cars, then you surely saw the kerfuffle over Ferrari’s first all-electric

Box founder Aaron Levie got us talking this week with a social media post suggesting that tech CEOs are “uniquely prone to AI psychosis.” On the latest episode of TechCrunch’s Equity podcast, Kirsten Korosec, Sean O’Kane, and I did our best to unpack Levie’s comment. For one thing, we noted that he isn’t disavowing AI

According to Crunchbase’s latest data around black founders, $643 million has poured into US Black-founded startups since the beginning of the year — an amount not seen since 2022, when Black founders raised $653 million in funding. For context, Black founders raised $942 million of all venture dollars last year (that’s 0.32% of the $290

Marie Phelan said she had never heard of MDMA before spotting a flyer seeking veterans suffering from post traumatic stress disorder. Now, she says the psychoactive drug more commonly known as ecstasy or molly has changed the trajectory of her life. "My experience of MDMA was that it just cracked my heart wide open," said

Piotr Swat | Lightrocket | Getty Images An experimental lung cancer drug from Akeso and Summit Therapeutics reduced the risk of death by 34% in a closely watched late-stage trial, according to results released Sunday. When combined with chemotherapy, the drug kept people with squamous non-small-cell lung cancer alive for a median of four months

Welcome back to TechCrunch Mobility, your hub for the future of transportation and now, more than ever, how AI is playing a part. To get this in your inbox, sign up here for free — just click TechCrunch Mobility! If you’re into EVs or sports cars, then you surely saw the kerfuffle over Ferrari’s first all-electric

Box founder Aaron Levie got us talking this week with a social media post suggesting that tech CEOs are “uniquely prone to AI psychosis.” On the latest episode of TechCrunch’s Equity podcast, Kirsten Korosec, Sean O’Kane, and I did our best to unpack Levie’s comment. For one thing, we noted that he isn’t disavowing AI

According to Crunchbase’s latest data around black founders, $643 million has poured into US Black-founded startups since the beginning of the year — an amount not seen since 2022, when Black founders raised $653 million in funding. For context, Black founders raised $942 million of all venture dollars last year (that’s 0.32% of the $290

Marie Phelan said she had never heard of MDMA before spotting a flyer seeking veterans suffering from post traumatic stress disorder. Now, she says the psychoactive drug more commonly known as ecstasy or molly has changed the trajectory of her life. "My experience of MDMA was that it just cracked my heart wide open," said

Piotr Swat | Lightrocket | Getty Images An experimental lung cancer drug from Akeso and Summit Therapeutics reduced the risk of death by 34% in a closely watched late-stage trial, according to results released Sunday. When combined with chemotherapy, the drug kept people with squamous non-small-cell lung cancer alive for a median of four months

Welcome back to TechCrunch Mobility, your hub for the future of transportation and now, more than ever, how AI is playing a part. To get this in your inbox, sign up here for free — just click TechCrunch Mobility! If you’re into EVs or sports cars, then you surely saw the kerfuffle over Ferrari’s first all-electric

Box founder Aaron Levie got us talking this week with a social media post suggesting that tech CEOs are “uniquely prone to AI psychosis.” On the latest episode of TechCrunch’s Equity podcast, Kirsten Korosec, Sean O’Kane, and I did our best to unpack Levie’s comment. For one thing, we noted that he isn’t disavowing AI

According to Crunchbase’s latest data around black founders, $643 million has poured into US Black-founded startups since the beginning of the year — an amount not seen since 2022, when Black founders raised $653 million in funding. For context, Black founders raised $942 million of all venture dollars last year (that’s 0.32% of the $290

Marie Phelan said she had never heard of MDMA before spotting a flyer seeking veterans suffering from post traumatic stress disorder. Now, she says the psychoactive drug more commonly known as ecstasy or molly has changed the trajectory of her life. "My experience of MDMA was that it just cracked my heart wide open," said

Piotr Swat | Lightrocket | Getty Images An experimental lung cancer drug from Akeso and Summit Therapeutics reduced the risk of death by 34% in a closely watched late-stage trial, according to results released Sunday. When combined with chemotherapy, the drug kept people with squamous non-small-cell lung cancer alive for a median of four months

Welcome back to TechCrunch Mobility, your hub for the future of transportation and now, more than ever, how AI is playing a part. To get this in your inbox, sign up here for free — just click TechCrunch Mobility! If you’re into EVs or sports cars, then you surely saw the kerfuffle over Ferrari’s first all-electric

Box founder Aaron Levie got us talking this week with a social media post suggesting that tech CEOs are “uniquely prone to AI psychosis.” On the latest episode of TechCrunch’s Equity podcast, Kirsten Korosec, Sean O’Kane, and I did our best to unpack Levie’s comment. For one thing, we noted that he isn’t disavowing AI

According to Crunchbase’s latest data around black founders, $643 million has poured into US Black-founded startups since the beginning of the year — an amount not seen since 2022, when Black founders raised $653 million in funding. For context, Black founders raised $942 million of all venture dollars last year (that’s 0.32% of the $290

Marie Phelan said she had never heard of MDMA before spotting a flyer seeking veterans suffering from post traumatic stress disorder. Now, she says the psychoactive drug more commonly known as ecstasy or molly has changed the trajectory of her life. "My experience of MDMA was that it just cracked my heart wide open," said

Piotr Swat | Lightrocket | Getty Images An experimental lung cancer drug from Akeso and Summit Therapeutics reduced the risk of death by 34% in a closely watched late-stage trial, according to results released Sunday. When combined with chemotherapy, the drug kept people with squamous non-small-cell lung cancer alive for a median of four months

Welcome back to TechCrunch Mobility, your hub for the future of transportation and now, more than ever, how AI is playing a part. To get this in your inbox, sign up here for free — just click TechCrunch Mobility! If you’re into EVs or sports cars, then you surely saw the kerfuffle over Ferrari’s first all-electric

Box founder Aaron Levie got us talking this week with a social media post suggesting that tech CEOs are “uniquely prone to AI psychosis.” On the latest episode of TechCrunch’s Equity podcast, Kirsten Korosec, Sean O’Kane, and I did our best to unpack Levie’s comment. For one thing, we noted that he isn’t disavowing AI

According to Crunchbase’s latest data around black founders, $643 million has poured into US Black-founded startups since the beginning of the year — an amount not seen since 2022, when Black founders raised $653 million in funding. For context, Black founders raised $942 million of all venture dollars last year (that’s 0.32% of the $290

Marie Phelan said she had never heard of MDMA before spotting a flyer seeking veterans suffering from post traumatic stress disorder. Now, she says the psychoactive drug more commonly known as ecstasy or molly has changed the trajectory of her life. "My experience of MDMA was that it just cracked my heart wide open," said

Piotr Swat | Lightrocket | Getty Images An experimental lung cancer drug from Akeso and Summit Therapeutics reduced the risk of death by 34% in a closely watched late-stage trial, according to results released Sunday. When combined with chemotherapy, the drug kept people with squamous non-small-cell lung cancer alive for a median of four months

Welcome back to TechCrunch Mobility, your hub for the future of transportation and now, more than ever, how AI is playing a part. To get this in your inbox, sign up here for free — just click TechCrunch Mobility! If you’re into EVs or sports cars, then you surely saw the kerfuffle over Ferrari’s first all-electric

Box founder Aaron Levie got us talking this week with a social media post suggesting that tech CEOs are “uniquely prone to AI psychosis.” On the latest episode of TechCrunch’s Equity podcast, Kirsten Korosec, Sean O’Kane, and I did our best to unpack Levie’s comment. For one thing, we noted that he isn’t disavowing AI

According to Crunchbase’s latest data around black founders, $643 million has poured into US Black-founded startups since the beginning of the year — an amount not seen since 2022, when Black founders raised $653 million in funding. For context, Black founders raised $942 million of all venture dollars last year (that’s 0.32% of the $290

Marie Phelan said she had never heard of MDMA before spotting a flyer seeking veterans suffering from post traumatic stress disorder. Now, she says the psychoactive drug more commonly known as ecstasy or molly has changed the trajectory of her life. "My experience of MDMA was that it just cracked my heart wide open," said

Piotr Swat | Lightrocket | Getty Images An experimental lung cancer drug from Akeso and Summit Therapeutics reduced the risk of death by 34% in a closely watched late-stage trial, according to results released Sunday. When combined with chemotherapy, the drug kept people with squamous non-small-cell lung cancer alive for a median of four months

Welcome back to TechCrunch Mobility, your hub for the future of transportation and now, more than ever, how AI is playing a part. To get this in your inbox, sign up here for free — just click TechCrunch Mobility! If you’re into EVs or sports cars, then you surely saw the kerfuffle over Ferrari’s first all-electric

Box founder Aaron Levie got us talking this week with a social media post suggesting that tech CEOs are “uniquely prone to AI psychosis.” On the latest episode of TechCrunch’s Equity podcast, Kirsten Korosec, Sean O’Kane, and I did our best to unpack Levie’s comment. For one thing, we noted that he isn’t disavowing AI

According to Crunchbase’s latest data around black founders, $643 million has poured into US Black-founded startups since the beginning of the year — an amount not seen since 2022, when Black founders raised $653 million in funding. For context, Black founders raised $942 million of all venture dollars last year (that’s 0.32% of the $290

Marie Phelan said she had never heard of MDMA before spotting a flyer seeking veterans suffering from post traumatic stress disorder. Now, she says the psychoactive drug more commonly known as ecstasy or molly has changed the trajectory of her life. "My experience of MDMA was that it just cracked my heart wide open," said

Piotr Swat | Lightrocket | Getty Images An experimental lung cancer drug from Akeso and Summit Therapeutics reduced the risk of death by 34% in a closely watched late-stage trial, according to results released Sunday. When combined with chemotherapy, the drug kept people with squamous non-small-cell lung cancer alive for a median of four months

Welcome back to TechCrunch Mobility, your hub for the future of transportation and now, more than ever, how AI is playing a part. To get this in your inbox, sign up here for free — just click TechCrunch Mobility! If you’re into EVs or sports cars, then you surely saw the kerfuffle over Ferrari’s first all-electric

Box founder Aaron Levie got us talking this week with a social media post suggesting that tech CEOs are “uniquely prone to AI psychosis.” On the latest episode of TechCrunch’s Equity podcast, Kirsten Korosec, Sean O’Kane, and I did our best to unpack Levie’s comment. For one thing, we noted that he isn’t disavowing AI

According to Crunchbase’s latest data around black founders, $643 million has poured into US Black-founded startups since the beginning of the year — an amount not seen since 2022, when Black founders raised $653 million in funding. For context, Black founders raised $942 million of all venture dollars last year (that’s 0.32% of the $290

Marie Phelan said she had never heard of MDMA before spotting a flyer seeking veterans suffering from post traumatic stress disorder. Now, she says the psychoactive drug more commonly known as ecstasy or molly has changed the trajectory of her life. "My experience of MDMA was that it just cracked my heart wide open," said

Piotr Swat | Lightrocket | Getty Images An experimental lung cancer drug from Akeso and Summit Therapeutics reduced the risk of death by 34% in a closely watched late-stage trial, according to results released Sunday. When combined with chemotherapy, the drug kept people with squamous non-small-cell lung cancer alive for a median of four months

Welcome back to TechCrunch Mobility, your hub for the future of transportation and now, more than ever, how AI is playing a part. To get this in your inbox, sign up here for free — just click TechCrunch Mobility! If you’re into EVs or sports cars, then you surely saw the kerfuffle over Ferrari’s first all-electric

Box founder Aaron Levie got us talking this week with a social media post suggesting that tech CEOs are “uniquely prone to AI psychosis.” On the latest episode of TechCrunch’s Equity podcast, Kirsten Korosec, Sean O’Kane, and I did our best to unpack Levie’s comment. For one thing, we noted that he isn’t disavowing AI

According to Crunchbase’s latest data around black founders, $643 million has poured into US Black-founded startups since the beginning of the year — an amount not seen since 2022, when Black founders raised $653 million in funding. For context, Black founders raised $942 million of all venture dollars last year (that’s 0.32% of the $290

Marie Phelan said she had never heard of MDMA before spotting a flyer seeking veterans suffering from post traumatic stress disorder. Now, she says the psychoactive drug more commonly known as ecstasy or molly has changed the trajectory of her life. "My experience of MDMA was that it just cracked my heart wide open," said

Piotr Swat | Lightrocket | Getty Images An experimental lung cancer drug from Akeso and Summit Therapeutics reduced the risk of death by 34% in a closely watched late-stage trial, according to results released Sunday. When combined with chemotherapy, the drug kept people with squamous non-small-cell lung cancer alive for a median of four months